soul trial oral semaglutide cardiovascular outcomes results 2025 nejm Editorial Fellow Harleen Marwah, MD, summarizes the trial. Read the full at NEJM.org (link in bio). , , #ACC25 #Cardiology #ClinicalTrials #NEJM SOUL: Oral Semaglutide Bests Usual
Description
What is included

Biocon is poised to advance its semaglutide generic development by evaluating Indias anti-obesity market dynamics, amid increasing price competition from domestic competitors
Explore Semaglutide vs Tirzepatide for weight loss in Naperville

Research-grade lyophilized peptide

Research suggests that GLP-1 agonists may also directly reduce the desire to drink fluids, compounding the dehydration risk
